Perrigo Company plc (PRGO)
Perrigo to Conduct Strategic Review of its Infant Formula Business
Perrigo to Conduct Strategic Review of its Infant Formula Business
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
BIO-TECHNE DECLARES DIVIDEND
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
Fortrea Reports Third Quarter 2025 Results
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
Elanco Animal Health Reports Third Quarter 2025 Results